ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Inder D. Mehta
Gary S. Kopf
Richard K. Shaw
John A. Elefteriades
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehta, I. D.
Right arrow Articles by Elefteriades, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehta, I. D.
Right arrow Articles by Elefteriades, J. A.

Ann Thorac Surg 1998;65:17-23
© 1998 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Should Angiographically Disease-Free Saphenous Vein Grafts Be Replaced at the Time of Redo Coronary Artery Bypass Grafting?

Inder D. Mehta, MD, Joy Weinberg, BS, Marc F. Jones, BS, George Tellides, MD, Gary S. Kopf, MD, Richard K. Shaw, MD, Barry L. Zaret, MD, John A. Elefteriades, MD

Section of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA

Dr Elefteriades, 121 FMB, 333 Cedar St, New Haven, CT 06437.

Presented at the Thirty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Feb 3–5, 1997.

Background. Controversy exists regarding the management of angiographically disease-free saphenous vein grafts at the time of redo coronary artery bypass grafting (CABG). Some authorities favor replacement of these disease-free grafts, arguing that occlusion is likely in the near future. Others believe that these grafts are "biologically privileged" and should not be replaced.

Methods. One hundred thirty-two consecutive patients (113 men, 19 women, aged 46 to 88 years, mean 67 years) underwent redo revascularization with one or more angiographically disease-free saphenous vein grafts at the time of redo CABG. Thirty-six patients had the disease-free grafts replaced (R) and 96 did not (NR). The mean interval from the first CABG was 9.25 years.

Results. Surgical mortality was comparable in the NR and R groups (5 of 96 or 5.2% versus 3 of 36 or 8.3%, respectively; p < 0.5). Survival at 1 and 3 years was higher in the NR group than the R group (98% versus 80%, and 95% vs. 66% respectively; p < 0.0001). Late myocardial infarction was less common in the NR group than in the R group (12 of 91 or 12.9% versus 12 of 33 or 36.4%; p < 0.003). Recurrent angina was less common in the NR than in the R group (21 of 91 or 23.1% versus 15 of 33 or 45.5%; p < 0.015). Cardiac hospitalization was required less commonly in the NR than in the R group (11 of 91 or 12.1% versus 12 of 33 or 36.4%; p < 0.002). In nondiseased grafts undergoing angiographic evaluation late after redo CABG, rate of new stenosis was lower in NR grafts than in R grafts (2 of 12 or 16.7% versus 2 of 3 or 66.7%; p < 0.05).

Conclusions. With a conservative approach that does not replace nondiseased saphenous vein grafts at redo CABG (1) there is no increase in operative mortality, (2) good late survival is obtained, (3) clinical ischemia related to the NR saphenous vein grafts is uncommon, and (4) NR grafts continue to be patent. We conclude that disease-free vein grafts may not require routine replacement at redo CABG. A randomized study is required for definitive resolution.




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. Liao, D. F. Kong, L. K. Shaw, M. H. Sketch Jr, C. A. Milano, K. L. Lee, and D. B. Mark
A New Anatomic Score for Prognosis After Cardiac Catheterization in Patients with Previous Bypass Surgery
J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1684 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. V. Bilfinger, J. A. Vosswinkel, C. M. Rialas, I. B. Krukenkamp, and G. B. Stefano
Functional assessment of disease-free saphenous vein grafts at redo coronary artery bypass grafting
Ann. Thorac. Surg., April 1, 2000; 69(4): 1183 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. D. Loop
Coronary artery surgery: the end of the beginning
Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 554 - 571.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1998 by The Society of Thoracic Surgeons.